Advertisement
Research Article| Volume 2, ISSUE 1, P3-19, March 1982

Download started.

Ok

Blood Components for Hemotherapy

  • Byron A. Myhre
    Correspondence
    Corresponding author: Department of Pathology, Harbor/UCLA Medical Center, 1000 W. Carson Street, Torrance, California 90509
    Affiliations
    Professor of Pathology, University of California at Los Angeles School of Medicine; Director of Immunopathology, Department of Pathology, Harbor/UCLA Medical Center, Torrance, California
    Search for articles by this author
  • George E. Harris
    Affiliations
    Assistant Professor, Department of Medical Technology, California State University Dominguez Hills; Blood Bank Administrative Senior Technologist, Department of Pathology, Harbor/UCLA Medical Center, Torrance, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31051-5
Blood Components for Hemotherapy
Previous ArticleForeword
Next ArticleMassive Transfusion
      This paper is only available as a PDF. To read, Please Download here.
      The effective use of blood components for transfusions requires a knowledge of their contents and the individual needs of the patient. The advantages and disadvantages of using whole blood, red cells, platelet concentrates, fresh frozen plasma, and cryoprecipitate are presented. Effective communication between the laboratory and the physician aids in the achievement of a beneficial clinical response.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Aster R.H.
        Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets.
        Blood. 1965; 26: 732-743
        • Avoy D.R.
        • Canuel M.L.
        • Otton B.M.
        • et al.
        Hemoglobin screening in prospective blood donors: A comparison of methods.
        Transfusion. 1977; 17: 261-264
        • Biggs R.
        Human Blood Coagulation, Haemostasis, and Thrombosis.
        Edition 2. Blackwell Scientific, Oxford1976: 258
        • Borucki D.T.
        Blood Component Therapy.
        Edition 3. American Association of Blood Banks, Washington, D.C.1981: 56
        • Buchholz D.H.
        • Young V.M.
        • Friedman N.R.
        • et al.
        Bacterial proliferation in platelet products stored at room temperature.
        N. Engl. J. Med. 1971; 285: 429-433
        • Button L.N.
        • Dewolf W.C.
        • Newburger P.E.
        • et al.
        The effects of irradiation on blood components.
        Transfusion. 1981; 21: 419-426
        • Cederbaum A.I.
        The appropriate use of plasma and plasma components in clinical medicine.
        in: Silver, H.: Blood, Blood Components and Derivatives in Transfusion Therapy. American Association of Blood Banks, Washington, D.C.1981: 123
        • Chambers R.W.
        • Foley H.T.
        • Schmidt P.J.
        Transmission of syphilis by fresh blood components.
        Transfusion. 1969; 9: 32-34
        • Code of Federal Regulation
        Title 21.
        United States Government Printing Office, Washington, D.C.1978

      10. Centers for Disease Control: Morbid. Mortal. Weekly Rpt., Sept 30, 1977, p. 327.

        • Dickson D.N.
        • Gregory M.A.
        Compatibility of blood with solutions containing calcium.
        S. Afr. Med. J. 1980; 57: 785-787
        • Epstein H.M.
        • Jarzensky D.
        • Zuckerman L.
        • et al.
        Plasma cholinesterase activity in bank blood.
        Anesth. Analg. 1980; 59: 211-214
        • Goldfinger D.
        • McGinnis M.H.
        Rh-incompatible platelet transfusions — Risks and consequences of sensitizing immunosuppressed patients.
        N. Eng. J. Med. 1971; 284: 942-944

      14. Greenwalt, T. J., Polesky, H. F., Chaplin, H., et al.: General Principles of Blood Transfusion. Edition 3. 1977, p. 104.

        • Grindon A.J.
        The use of packed red blood cells.
        J.A.M.A. 1976; 235: 389
        • Grunow J.E.
        • Lubet R.A.
        • Ferguson M.J.
        • et al.
        Preferential decrease in thymus dependent lymphocytes during storage at 4C in anticoagulant.
        Transfusion. 1976; 16: 610-615
        • Hemphill B.H.
        Blood collection and use by AABB institutional members (1976).
        Transfusion. 1979; 19: 365-370
        • Howland W.S.
        • Bellville J.W.
        • Zucker M.B.
        • et al.
        Massive blood replacement. V. Failure to observe citrate intoxication.
        Surg. Gynecol. Obstet. 1957; 105: 529-540
        • Howland W.S.
        • Schweizer O.
        • Fleisher M.
        • et al.
        Fibrinogen and albumin deficiencies associated with packed red blood cell transfusions.
        Anesth. Analg. 1975; 54: 89-93
        • Lanzkowsky P.
        Hematologic emergencies.
        Pediatr. Clin. North Am. 1979; 26: 909-930
        • McClellan M.A.
        • Alexander J.W.
        The opsonic activity of stored blood.
        Transfusion. 1977; 17: 227-232
        • McCullough J.
        • Yunis E.J.
        • Benson S.J.
        • et al.
        Effect of blood-bank storage on leucocyte function.
        Lancet. 1969; 2: 1333-1337
        • McCullough J.
        • Carter S.J.
        • Quie P.G.
        Preservation of opsonic activity against Staphylococcus aureus and Escherichia coli in bank blood.
        J. Lab. Clin Med. 1972; 79: 886-892
        • Mohr J.
        • Killebrew L.
        • Muchmore H.G.
        • et al.
        Transfer of delayed hypersensitivity.
        J.A.M.A. 1969; 207: 517-519
        • Moore G.E.
        • Peck C.C.
        • Sohmer P.R.
        • et al.
        Some properties of blood stored in anticoagulant CPDA-1 solution — A brief summary.
        Transfusion. 1980; 21: 135-137
        • Murphy S.
        • Sayar S.
        • Gardner F.H.
        Storage of platelet concentrates at 22C.
        Blood. 1970; 35: 549-557
        • Myhre B.A.
        A Seminar on Blood Components.
        American Association of Blood Banks, Washington, D.C.1977

      28. Myhre, B. A.: Unpublished results.

        • Ness P.M.
        • Perkins H.A.
        Cryoprecipitate as a reliable source of fibrinogen replacement.
        J.A.M.A. 1979; 241: 1690

      30. Oberman, H. A.: Standards for Blood Banks and Transfusion Services. Edition 10. American Association of Blood Banks, 1981, p. 46.

        • Pfisterer H.
        • Theirfelder S.T.
        • Stich W.
        ABO-Rh blood groups and platelet transfusions.
        Blut. 1968; 17: 1-5
        • Pineda A.
        • Taswell H.
        Transfusion reactions associated with anti-IgA antibodies: Report of four cases and review of the literature.
        Transfusion. 1975; 15: 10-15
        • Pool J.G.
        • Shannon M.E.
        Production of high-potency concentrates of antihemophilic globulin in a closed bag system.
        N. Engl. J. Med. 1965; 273: 1443-1447
        • Redeker A.G.
        • Hopkins C.E.
        • Jackson B.
        • et al.
        A controlled study of the safety of pooled plasma stored in the liquid state at 30-32C for six months.
        Transfusion. 1968; 8: 60-64
        • Ryden S.E.
        • Oberman H.A.
        Compatibility of common intravenous solutions with CPD blood.
        Transfusion. 1975; 15: 250-255
        • Saba T.M.
        • Jaffe E.A.
        Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.
        Am. J. Med. 1980; 68: 577-593
        • Schechter D.C.
        • Swan H.
        Biochemical alterations of preserved blood.
        Arch. Surg. 1962; 84: 17-24
        • Shin B.
        • Mackenzie C.F.
        • Friedman S.
        • et al.
        Hypokalemia after trauma and component transfusion therapy.
        Anesthesiol. 1979; 51: S206
        • Simon T.L.
        • Henderson R.
        Coagulation factor activity in platelet concentrates.
        Transfusion. 1979; 19: 186-189
        • Straus R.G.
        • Crouch J.
        Preservation of neutrophils in CPD-adenine.
        Transfusion. 1981; 21: 354-356
        • Valeri C.R.
        • Hirsch N.M.
        Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate* potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose stored human red blood cells.
        J. Lab. Clin. Med. 1969; 73: 722-733
        • Wenz B.
        • Apuzzo J.H.
        • Akuja K.K.
        The preparation of leukocyte-poor red cells from liquid stored blood: An evaluation of the haemonetics 102 cell washing system.
        Transfusion. 1980; 20: 306-310

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31051-5

      Copyright

      © 1982 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX